BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21159832)

  • 1. Cortisol during the day in patients with systemic lupus erythematosus or primary Sjogren's syndrome.
    van der Goes MC; Bossema ER; Hartkamp A; Godaert GL; Jacobs JW; Kruize AA; Derksen RH; Bijlsma JW; Geenen R
    J Rheumatol; 2011 Feb; 38(2):285-8. PubMed ID: 21159832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyses of hair and salivary cortisol for evaluating hypothalamic-pituitary-adrenal axis activation in patients with autoimmune disease.
    Montero-López E; Santos-Ruiz A; González R; Navarrete-Navarrete N; Ortego-Centeno N; Martínez-Augustín O; Rodríguez-Blázquez M; Peralta-Ramírez MI
    Stress; 2017 Nov; 20(6):541-548. PubMed ID: 28853298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of salivary beta 2 microglobulin concentration for diagnosis of Sjögren's syndrome].
    Du D; Pu Y; Zhao Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Feb; 19(1):72-4. PubMed ID: 10453557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nailfold capillary abnormalities in patients with Sjögren's syndrome and systemic lupus erythematosus.
    Ohtsuka T
    Br J Dermatol; 1997 Jan; 136(1):94-6. PubMed ID: 9039302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of exercise in the rehabilitation of patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome.
    Strömbeck B; Jacobsson LT
    Curr Opin Rheumatol; 2007 Mar; 19(2):197-203. PubMed ID: 17278938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialochemistry and cortisol levels in patients with Sjogren's syndrome.
    Miller BE; Deutsch O; Redlich M; Konttinen YT; Benoliel R; Zaks B; Davidovich E; Palmon A; Aframian DJ
    Oral Dis; 2012 Apr; 18(3):255-9. PubMed ID: 22050355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of circulating matrix metalloproteinase-9 are associated with a dysregulated cortisol rhythm--A case-control study of coronary artery disease.
    Szymanowski A; Nijm J; Kristenson M; Jonasson L
    Psychoneuroendocrinology; 2011 Jan; 36(1):139-43. PubMed ID: 20674181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofunction of the stress axis in Sjögren's syndrome.
    Johnson EO; Vlachoyiannopoulos PG; Skopouli FN; Tzioufas AG; Moutsopoulos HM
    J Rheumatol; 1998 Aug; 25(8):1508-14. PubMed ID: 9712092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence and clinical features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis and Sjögren's syndrome].
    Ostuni P; Botsios C; Sfriso P; Bertagnin A; Cozzi F; Doria A; Todesco S
    Minerva Med; 2002 Jun; 93(3):203-9. PubMed ID: 12094151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in the ratio of matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 in saliva from patients with primary Sjögren's syndrome.
    Asatsuma M; Ito S; Watanabe M; Takeishi H; Nomura S; Wada Y; Nakano M; Gejyo F; Igarashi A
    Clin Chim Acta; 2004 Jul; 345(1-2):99-104. PubMed ID: 15193983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xerostomia in Sjögren's syndrome and lupus erythematosus: a comparative histological and immunofluorescence study of minor salivary glands alterations.
    Fernandes JD; Nico MM; Aoki V; Bologna S; Romiti R; Levy-Neto M; Lourenço SV
    J Cutan Pathol; 2010 Apr; 37(4):432-8. PubMed ID: 19614726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for altered hypothalamus-pituitary-adrenal axis functioning in systemic hypertension: blunted cortisol response to awakening and lower negative feedback sensitivity.
    Wirtz PH; von Känel R; Emini L; Ruedisueli K; Groessbauer S; Maercker A; Ehlert U
    Psychoneuroendocrinology; 2007 Jun; 32(5):430-6. PubMed ID: 17433557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren's syndrome in systemic lupus erythematosus.
    Andonopoulos AP; Skopouli FN; Dimou GS; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1990 Feb; 17(2):201-4. PubMed ID: 2319519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
    Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function.
    Valtysdóttir ST; Wide L; Hällgren R
    J Rheumatol; 2001 Jun; 28(6):1259-65. PubMed ID: 11409117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sjogren's syndrome in SLE: Part 2. An examination of the clinical significance of Sjogren's syndrome by comparison of its frequency in typical and atypical forms of SLE, overlap syndromes and scleroderma.
    Grennan DM; Ferguson M; Ghobarey AE; Williamson J; Dick WC; Buchanan WW
    N Z Med J; 1977 Oct; 86(598):376-9. PubMed ID: 272547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of soluble complement receptor 2/CD21 in systemic lupus erythomatosus and Sjogren's syndrome but not juvenile arthritis.
    Masilamani M; Nowack R; Witte T; Schlesier M; Warnatz K; Glocker MO; Peter HH; Illges H
    Scand J Immunol; 2004 Dec; 60(6):625-30. PubMed ID: 15584974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.